Details for EU Drug Strategy (2013-20)

Author: European Union

The new EU drug strategy for 2013–20 was adopted on 7 December 2012.  The framework, aim and objectives of the Strategy will serve as a basis for two consecutive four-year EU Drugs Action plans. The strategy directs and requires collective EU action in international forums, such as the UN Commission on Narcotic Drugs and the UN General Assembly, and the strategy will have an important role in EC funding priorities. The strategy sets out the need for evaluation of outcomes achieved in supply side enforcement as well as demand reduction. “Risk and harm reduction” is a notable feature of the strategy and the strategy has a focus on HIV, HCV, and overdose. The strategy has more emphasis on human rights than the previous strategy and seeks to encourage civil society participation in policy, including the involvement of young people and people who use drugs.